Quick Answer
VACCINEX, INC. reported Common Stock Shares Outstanding of 2.68 million shares for the year ending 2024.
- VACCINEX, INC. showed an increase of +199.9% in Common Stock Shares Outstanding from 2023 to 2024.
- This data is from VACCINEX, INC.'s annual report (Form 10-K), filed with the SEC on April 15, 2025.
- XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2017 to 2024), VACCINEX, INC.'s Common Stock Shares Outstanding has grown by 142.8%.
- Historical annual values: Fiscal year 2024: 2.68 million shares | Fiscal year 2023: 892,617 shares | Fiscal year 2022: 237,527 shares | Fiscal year 2021: 30.80 million shares | Fiscal year 2020: 22.39 million shares | Fiscal year 2019: 14.89 million shares | Fiscal year 2018: 11.48 million shares | Fiscal year 2017: 1.10 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: